Skip to main content

Table 1 Comparison of laboratory variables in control and chronic kidney disease dogs

From: Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease

Laboratory Variable Control
(n = 10)
All CKD
(n = 27)
Stage 1
(n = 8)
Stage 2
(n = 8)
Stage 3
(n = 7)
Stage 4
(n = 4)
UrKl/Cr
(pg/gCr)
13.16
(5.75–34.84)
5.85
(0.08–82.28)
12.32
(3.03–82.28)
13.57
(2.15-18.00)
0.81
(0.30–4.37)
3.98
(0.08–5.85)
Serum Klotho
(pg/mL)
132.25
(57.46-169.33)
59.13
(0.47-189.13)
78.32
(10.47-122.47)
30.14
(0.47–72.47)
19.8
(2.47–70.47)
127.47
(77.13-189.13)
SDMA
(µg/dL)
8
(5–13)
28
(8–74)
13.5
(8–17)
22.5
(18–31)
37
(34–47)
58.5
(52–74)
Creatinine
(mg/dL)
0.8
(0.6-1)
1.9
(0.7–11.1)
1.1
(0.7–1.3)
1.75
(1.5–2.3)
3
(1.8–4.2)
5
(3.8–11.1)
BUN
(mg/dL)
21.4
(9-33.8)
55.7
(6.8-167.7)
25.05
(6.8–47.5)
51.25
(19-108.2)
89
(43.4-111.8)
135.6
(76.7-167.7)
Phosphorus
(mg/dL)
3.7
(3.1–5.2)
3.9
(2.9–19)
3.3
(2.9–3.8)
4
(2.9–5.3)
5.9
(3.1–8.38)
11.15
(4.39-19)
  1. Results are presented as median and range.
  2. UrKl/Cr, urine klotho-to-creatinine ratio; SDMA, symmetric dimethylarginine; BUN, blood urea nitrogen.